IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Omega Fund Management, LLC

Q2 2021 Holdings

Filed 2021-08-16 | 2 holdings | $279.2K | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2021-11-15) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arcutis Biothereapeutics(ARQT)Common Stock03969K108$17.0M623,83650.6%
Atea Pharmaceuticals(AVIR)Common Stock04683R106$16.0M746,86847.7%
Nuvation Bio(NUVB)ACommon Stock67080N101$262.7K28,212,37694.1%
Replimune Group(REPL)Common Stock76029N106$192.4K5,008,2450.6%
Morphic HoldingCommon Stock61775R105$101.4K1,767,3500.3%
Kronos Bio(KRON1USD)Common Stock50107A104$91.4K3,818,2830.3%
Ikena OncologyCommon Stock45175G108$31.6K2,249,1230.1%
Gossamer Bio(GOSS)Common Stock38341P102$27.0K3,320,6080.1%
Spruce BiosciencesCommon Stock85209E109$24.2K2,161,0220.1%
Immunic(IMUX)Common Stock4525EP101$21.9K1,788,1600.1%
Paratek PharmaceuticalsCommon Stock699374302$17.7K2,600,4100.1%
Sana Biotechnology, Inc.(SANA)ACommon Stock799566104$16.6K843,7505.9%
Syros PharmaceuticalsCommon Stock87184Q107$12.4K2,274,8310.0%
Alpine Immune Sciences(NVLSEUR)Common Stock02083G100$11.6K1,284,9000.0%
Essa Pharma(EPIEUR)Common Stock29668H708$9.4K328,1960.0%
Checkmate PharmaceuticalsCommon Stock162818108$8.0K1,335,0500.0%
Omega Alpha SpacCommon StockG6749V107$5.0K501,0000.0%
Cidara TherapeuticsCommon Stock171757107$4.1K2,005,2490.0%
FibroGen(FGENEUR)Common Stock31572Q808$3.5K130,6460.0%
ObsEvaCommon StockH5861P103$3.0K999,3640.0%
Trevi Therapeutics(TRVI)Common Stock89532M101$2.8K1,263,4080.0%
Immunocore Holdings(IMCR)Common Stock45258D105$2.0K51,5350.0%
Jounce Therapeutics(JNCEEUR)Common Stock481116101$1.9K275,5130.0%